These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36521639)

  • 1. Engineered ionizable lipid nanoparticles mediated efficient siRNA delivery to macrophages for anti-inflammatory treatment of acute liver injury.
    Zhang H; Ding F; Zhu Z; Sun Q; Yang C
    Int J Pharm; 2023 Jan; 631():122489. PubMed ID: 36521639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a potent ionizable lipid for efficient macrophage transfection and systemic anti-interleukin-1β siRNA delivery against acute liver failure.
    Ding F; Zhang H; Li Q; Yang C
    J Mater Chem B; 2021 Jul; 9(25):5136-5149. PubMed ID: 34132324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered ionizable lipid siRNA conjugates enhance endosomal escape but induce toxicity in vivo.
    Biscans A; Ly S; McHugh N; Cooper DA; Khvorova A
    J Control Release; 2022 Sep; 349():831-843. PubMed ID: 35917865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of cationic lipid composition on gene silencing properties of lipid nanoparticle formulations of siRNA in antigen-presenting cells.
    Basha G; Novobrantseva TI; Rosin N; Tam YY; Hafez IM; Wong MK; Sugo T; Ruda VM; Qin J; Klebanov B; Ciufolini M; Akinc A; Tam YK; Hope MJ; Cullis PR
    Mol Ther; 2011 Dec; 19(12):2186-200. PubMed ID: 21971424
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Kawase W; Kurotaki D; Suzuki Y; Ishihara H; Ban T; Sato GR; Ichikawa J; Yanai H; Taniguchi T; Tsukahara K; Tamura T
    Mol Ther Nucleic Acids; 2021 Sep; 25():708-715. PubMed ID: 34589288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted lipid nanoparticle delivery of calcitriol to human monocyte-derived macrophages in vitro and in vivo: investigation of the anti-inflammatory effects of calcitriol.
    Rafique A; Etzerodt A; Graversen JH; Moestrup SK; Dagnæs-Hansen F; Møller HJ
    Int J Nanomedicine; 2019; 14():2829-2846. PubMed ID: 31114197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of physiological and biochemical barriers to siRNA liver delivery via lipid nanoparticle platform.
    Xu Y; Ou M; Keough E; Roberts J; Koeplinger K; Lyman M; Fauty S; Carlini E; Stern M; Zhang R; Yeh S; Mahan E; Wang Y; Slaughter D; Gindy M; Raab C; Thompson C; Hochman J
    Mol Pharm; 2014 May; 11(5):1424-34. PubMed ID: 24588618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which Lipid Nanoparticle (LNP) Designs Work? A Simple Kinetic Model Linking LNP Chemical Structure to In Vivo Delivery Performance.
    Roh EH; Sullivan MO; Epps TH
    ACS Appl Mater Interfaces; 2024 Mar; 16(11):13399-13410. PubMed ID: 38466900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficiency of lipid nanoparticles with an original cationic lipid as a siRNA delivery system for macrophages and dendritic cells.
    Uemura Y; Naoi T; Kanai Y; Kobayashi K
    Pharm Dev Technol; 2019 Mar; 24(3):263-268. PubMed ID: 29688101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of amino acid-modified biodegradable lipid nanoparticles for siRNA delivery.
    Patel P; Fetse J; Lin CY; Guo Y; Hasan MR; Nakhjiri M; Zhao Z; Jain A; Cheng K
    Acta Biomater; 2022 Dec; 154():374-384. PubMed ID: 36191773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics.
    Kulkarni JA; Witzigmann D; Chen S; Cullis PR; van der Meel R
    Acc Chem Res; 2019 Sep; 52(9):2435-2444. PubMed ID: 31397996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA.
    Chen S; Tam YYC; Lin PJC; Sung MMH; Tam YK; Cullis PR
    J Control Release; 2016 Aug; 235():236-244. PubMed ID: 27238441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Charge-reversible lipid derivative: A novel type of pH-responsive lipid for nanoparticle-mediated siRNA delivery.
    Hirai Y; Saeki R; Song F; Koide H; Fukata N; Tomita K; Maeda N; Oku N; Asai T
    Int J Pharm; 2020 Jul; 585():119479. PubMed ID: 32473372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of Hepatic Inflammation via Systemic siRNA Delivery by Membrane-Disruptive and Endosomolytic Helical Polypeptide Hybrid Nanoparticles.
    He H; Zheng N; Song Z; Kim KH; Yao C; Zhang R; Zhang C; Huang Y; Uckun FM; Cheng J; Zhang Y; Yin L
    ACS Nano; 2016 Feb; 10(2):1859-70. PubMed ID: 26811880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid Nanoparticle Formulations for Enhanced Co-delivery of siRNA and mRNA.
    Ball RL; Hajj KA; Vizelman J; Bajaj P; Whitehead KA
    Nano Lett; 2018 Jun; 18(6):3814-3822. PubMed ID: 29694050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipidoid-siRNA Nanoparticle-Mediated IL-1β Gene Silencing for Systemic Arthritis Therapy in a Mouse Model.
    Song P; Yang C; Thomsen JS; Dagnæs-Hansen F; Jakobsen M; Brüel A; Deleuran B; Kjems J
    Mol Ther; 2019 Aug; 27(8):1424-1435. PubMed ID: 31153827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular-Level Structural Analysis of siRNA-Loaded Lipid Nanoparticles by
    Ueda K; Sakagawa Y; Saito T; Fujimoto T; Nakamura M; Sakuma F; Kaneko S; Tokumoto T; Nishimura K; Takeda J; Arai Y; Yamamoto K; Ikeda Y; Higashi K; Moribe K
    Mol Pharm; 2023 Sep; 20(9):4729-4742. PubMed ID: 37606988
    [No Abstract]   [Full Text] [Related]  

  • 18. On the Formation and Morphology of Lipid Nanoparticles Containing Ionizable Cationic Lipids and siRNA.
    Kulkarni JA; Darjuan MM; Mercer JE; Chen S; van der Meel R; Thewalt JL; Tam YYC; Cullis PR
    ACS Nano; 2018 May; 12(5):4787-4795. PubMed ID: 29614232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery.
    Zimmermann CM; Baldassi D; Chan K; Adams NBP; Neumann A; Porras-Gonzalez DL; Wei X; Kneidinger N; Stoleriu MG; Burgstaller G; Witzigmann D; Luciani P; Merkel OM
    J Control Release; 2022 Nov; 351():137-150. PubMed ID: 36126785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient Delivery of Globotriaosylceramide Synthase siRNA using Polyhistidine-Incorporated Lipid Nanoparticles.
    Kim IG; Jung WH; You G; Lee H; Shin YJ; Lim SW; Chung BH; Mok H
    Macromol Biosci; 2023 Apr; 23(4):e2200423. PubMed ID: 36728673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.